List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 47 studies with search of: Hemoglobin SC Disease
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed The Effect of Oral Magnesium Pidolate on How Often Painful Crises Happens in Patients With Hemoglobin SC Disease
Condition: Hemoglobin SC Disease
Intervention: Drug: Mg Pidolate
2 Terminated Evaluating the Safety and Effectiveness of Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease (CHAMPS)
Condition: Hemoglobin SC Disease
Interventions: Drug: Hydroxyurea;   Drug: Magnesium Pidolate;   Other: Placebo Pills and Placebo Liquid
3 Recruiting Allogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathies
Conditions: Sickle Cell Disease;   HEMOGLOBIN SS;   HEMOGLOBIN SC;   Hemoglobin Sb0/+
Interventions: Procedure: ALLOGENEIC BMT/SCT Infusion;   Drug: Busulfan;   Biological: Campath 1H;   Drug: Cyclophosphamide and Mesna
4 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
5 Completed A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Conditions: Hemoglobin SC Disease;   Sickle Cell Anemia
Intervention: Drug: Recombinant-methionyl human stem cell factor
6 Recruiting Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Hemoglobin SC Disease
Interventions: Behavioral: PAINReportIt;   Behavioral: PAINUCope;   Behavioral: PAINConsultN
7 Recruiting Evaluating an Educational Program Geared for Parents and Aimed at Improving Academic Success in Children With Sickle Cell Disease
Conditions: Hemoglobin SC Disease;   Anemia, Sickle Cell
Intervention: Behavioral: Parent Educational Support Program
8 Enrolling by invitation A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
Condition: Hemoglobin SC Disease
Interventions: Behavioral: General Tutoring;   Behavioral: Memory Training
9 Recruiting Evaluating the Safety and Effectiveness of Stem Cell Transplants From Unrelated Donors in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
Condition: Hemoglobin SC Disease
Intervention: Biological: Hematopoietic Stem Cell Transplantation
10 Active, not recruiting Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Conditions: Hemoglobinopathies;   Anemia, Sickle Cell;   Hemoglobin SC Disease;   Thalassemia;   Thalassemia Major
Interventions: Drug: Busulfex;   Drug: Fludarabine;   Drug: FK506;   Drug: Prednisone
11 Terminated Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
Conditions: Sickle Cell Anemia;   Hemoglobinopathy;   Thalassemia
Interventions: Drug: Campath -1H;   Drug: Dilantin;   Drug: Busulfan;   Drug: Cyclophosphamide
12 Active, not recruiting Far Infrared Radiation for Sickle Cell Pain Management
Condition: Anemia, Sickle Cell
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
13 Active, not recruiting Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
Conditions: Hemoglobinopathies;   Sickle Cell Disease;   Thalassemia
Interventions: Drug: Busulfex;   Drug: Fludarabine;   Drug: Alemtuzumab;   Procedure: Stem Cell Transfusion
14 Recruiting A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
Condition: Anemia
Intervention: Drug: methoxy polyethylene glycol-epoetin beta [Mircera]
15 Terminated A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
Condition: Anemia
Interventions: Drug: methoxy polyethylene glycol-epoetin beta [Mircera];   Drug: Supportive treatment
16 Active, not recruiting A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Condition: Anemia
Intervention: Drug: methoxy polyethylene glycol-epoetin beta
17 Active, not recruiting A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease Not Treated With ESA or on Dialysis.
Condition: Anemia
Intervention: Drug: methoxy polyethylene glycol-epoetin beta [Mircera]
18 Recruiting MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
Condition: Anemia
Intervention: Drug: methoxy polyethylene glycol-epoetin beta [Mircera]
19 Completed A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
Condition: Anemia
Interventions: Drug: methoxy polyethylene glycol-epoetin beta [Mircera];   Drug: epoetin alfa or beta
20 Active, not recruiting A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
Condition: Anemia
Intervention: Drug: methoxy polyethylene glycol-epoetin beta [Mircera]

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services